Monograph Details
|
|
Eye Disorders
> Glaucoma
|
|
LUMIGAN |
| Manufacturer |
|
Allergan |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Prostamide analogue. |
| Generic Name |
|
Bimatoprost 0.03%; oph soln; contains benzalkonium chloride. |
| Indications |
|
Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension. |
| Children |
|
Not recommended. |
| Adults |
|
1 drop once daily in the PM. |
| Precautions |
|
Do not exceed recommended dose. Renal or hepatic impairment. Ocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Allow at least 5 minutes between application of other topical ophthalmic agents. |
| Adverse Reactions |
|
Conjunctival hyperemia, eyelash growth, ocular itching or dryness, visual disturbances, foreign body sensation, other local effects, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, blepharitis, cataract, keratitis, photophobia, infection, headache, abnormal liver function tests, asthenia, hirsutism. |
| How Supplied |
|
Soln—2.5mL, 5mL, 7.5mL |
|
|
|
|
